Aggregator
Age-Dependent Metabolomic Signatures of Dietary Restriction in Mice
Caloric (CR) or dietary (DR) restriction improves health and extends lifespan in multiple species. However, the beneficial effects of DR may diminish if introduced late in life, emphasizing the importance of timing for promoting healthspan and avoiding adverse outcomes. Using a metabolomics approach, we investigated the metabolic responses in plasma, liver, and kidney of mice on acute and chronic DR at various ages. Two hundred and five mice including young (2-month-old; n = 72), middle-aged...
Antibodies and T cells join forces for sustained HIV remission
Correlates of HIV-1 control after combination immunotherapy
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
CD8<sup>+</sup> T cell stemness precedes post-intervention control of HIV viremia
Spineless creatures, possibly the world’s oldest beer receipt and more: 2025’s best Books in brief
China wants to lead the world on AI regulation — will the plan work?
David Baltimore obituary: virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS
Nature at its weirdest: what metamorphosis reveals about science and ourselves
Cooking up a storm of air pollution
Climbing through the silver mine: my work as a geologist
The mystery of emerald green — cracked
AI finds signs of life in ancient rocks
Editorial Expression of Concern: Cytokinesis failure generating tetraploids promotes tumorigenesis in <i>p53</i>-null cells
Seeking greater independence, Europe boosts space agency budget
X-ray observatory and mission to Saturn’s moon Enceladus win as ESA’s science program sees growth
Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases
Monoclonal antibodies approved for Alzheimer's disease (AD), such as lecanemab and aducanumab, have been shown to enhance microglial phagocytic function, underscoring the therapeutic relevance of microglia in neurodegenerative diseases (NDDs). Emerging evidence implicates lipid droplets (LDs) in brain aging and NDDs, particularly through LDs-laden microglia known as lipid droplet-accumulating microglia (LDAM), which exhibit impaired phagocytosis, elevated oxidative stress, and dysregulated lipid...
Quantifying the waning of humoral immunity
Immunological memory is a defining feature of immunity, and a quantitative description of how it wanes would help better understand the processes underlying its maintenance and estimate the duration of protection after immunization. We analyzed the waning of antibodies to a panel of virus and vaccine antigens and found that a power-law model captured both the initial rapid decline and much slower subsequent waning. Importantly, accounting for the time post-immunization at which the waning was...
Barriers and motivators of geriatric engagement in digital therapeutics: A narrative review
The adoption of digital therapeutics among older adults presents both opportunities and challenges in modern healthcare. While these technologies enhance disease management, autonomy, and quality of life, engagement remains hindered by cognitive, emotional, systemic, and sociocultural barriers. This narrative review synthesizes findings from 76 peer-reviewed studies identified through Scopus and Web of Science (2010-2024) to examine key factors influencing geriatric engagement with digital...
Rural-Urban migration of children and the older population: identifying challenges and adaptive strategies in Iran with a qualitative study
BACKGROUND: The phenomenon of population aging and the migration of young people from rural to urban areas, particularly in Iran's rural regions, has led to a higher growth rate of aging populations. This qualitative study aimed to investigate the effects of children's migration on the physical, mental, and social health of older adults in Kerman province and to identify their spontaneous adaptive strategies.
Microglial lipid droplets as therapeutic targets in age-related neurodegenerative diseases
Monoclonal antibodies approved for Alzheimer's disease (AD), such as lecanemab and aducanumab, have been shown to enhance microglial phagocytic function, underscoring the therapeutic relevance of microglia in neurodegenerative diseases (NDDs). Emerging evidence implicates lipid droplets (LDs) in brain aging and NDDs, particularly through LDs-laden microglia known as lipid droplet-accumulating microglia (LDAM), which exhibit impaired phagocytosis, elevated oxidative stress, and dysregulated lipid...